14-hydroxyclarithromycin has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, SY; Decourt, JP; Fourtillan, JB; Girault, J; Granneman, GR; Pichotta, PJ | 1 |
1 other study(ies) available for 14-hydroxyclarithromycin and Liver Dysfunction
| Article | Year |
|---|---|
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics.
Topics: Chromatography, High Pressure Liquid; Clarithromycin; Half-Life; Humans; Liver Diseases; Metabolic Clearance Rate; Middle Aged | 1993 |